Aminologics Co.Ltd (074430) — Cash Flow-to-Debt Ratio
Aminologics Co.Ltd (074430) has a Cash Flow-to-Debt Ratio of -0.15x as of September 2025, meaning its operating cash flow of ₩-4.16 Billion could theoretically repay 0% of its total liabilities (₩26.95 Billion) in one year. See 074430 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aminologics Co.Ltd Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Aminologics Co.Ltd across 12 annual periods. Also explore Aminologics Co.Ltd (074430) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Aminologics Co.Ltd (2008–2024)
Year-by-year debt coverage analysis for Aminologics Co.Ltd. For market capitalisation and broader financial context, see Aminologics Co.Ltd (074430) total market value.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.47x | ₩7.47 Billion | ₩5.09 Billion | ▲ +2288.3% |
| 2023 | -0.07x | ₩-218.15 Million | ₩3.26 Billion | ▼ -105.4% |
| 2022 | 1.25x | ₩5.23 Billion | ₩4.18 Billion | ▲ +682.1% |
| 2021 | 0.16x | ₩935.52 Million | ₩5.85 Billion | ▼ -40.6% |
| 2020 | 0.27x | ₩1.77 Billion | ₩6.57 Billion | ▼ -55.8% |
| 2019 | 0.61x | ₩3.60 Billion | ₩5.92 Billion | ▼ -51.0% |
| 2018 | 1.24x | ₩4.56 Billion | ₩3.67 Billion | ▲ +75.0% |
| 2017 | 0.71x | ₩3.00 Billion | ₩4.23 Billion | ▼ -23.2% |
| 2016 | 0.92x | ₩4.14 Billion | ₩4.48 Billion | ▲ +223.5% |
| 2015 | 0.29x | ₩1.93 Billion | ₩6.75 Billion | ▲ +193.8% |
| 2014 | -0.30x | ₩-2.07 Billion | ₩6.78 Billion | ▼ -134.4% |
| 2008 | 0.89x | ₩12.19 Billion | ₩13.77 Billion | — |